103 related articles for article (PubMed ID: 22054967)
21. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
22. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
[TBL] [Abstract][Full Text] [Related]
23. Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.
Zhao Y; Huai Y; Jin J; Geng M; Li JX
Menopause; 2011 Jun; 18(6):690-7. PubMed ID: 21228726
[TBL] [Abstract][Full Text] [Related]
24. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
Kim MH; Ryu SY; Bae MA; Choi JS; Min YK; Kim SH
Food Chem Toxicol; 2008 Nov; 46(11):3375-82. PubMed ID: 18786594
[TBL] [Abstract][Full Text] [Related]
25. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss.
Li JX; Liu J; He CC; Yu ZY; Du Y; Kadota S; Seto H
Maturitas; 2007 Sep; 58(1):59-69. PubMed ID: 17658706
[TBL] [Abstract][Full Text] [Related]
26. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
[TBL] [Abstract][Full Text] [Related]
27. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
Ishida M; Amano S
J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha.
van Beek EM; de Vries TJ; Mulder L; Schoenmaker T; Hoeben KA; Matozaki T; Langenbach GE; Kraal G; Everts V; van den Berg TK
FASEB J; 2009 Dec; 23(12):4081-90. PubMed ID: 19667119
[TBL] [Abstract][Full Text] [Related]
29. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
Sugawara K; Hamada M; Hosoi S; Tamaoki T
Anal Biochem; 1998 Jan; 255(2):204-10. PubMed ID: 9451505
[TBL] [Abstract][Full Text] [Related]
30. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of D-003, a mixture of high-molecular-weight aliphatic acids from sugarcane wax, and pravastatin on bones and osteoclast apoptosis of ovariectomized rats.
Mendoza S; Noa M; Mas R; Mendoza N
Drugs Exp Clin Res; 2005; 31(5-6):181-91. PubMed ID: 16425974
[TBL] [Abstract][Full Text] [Related]
32. Fucoxanthin induces apoptosis in osteoclast-like cells differentiated from RAW264.7 cells.
Das SK; Ren R; Hashimoto T; Kanazawa K
J Agric Food Chem; 2010 May; 58(10):6090-5. PubMed ID: 20420432
[TBL] [Abstract][Full Text] [Related]
33. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
34. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
Bonnelye E; Chabadel A; Saltel F; Jurdic P
Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
[TBL] [Abstract][Full Text] [Related]
35. Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts.
Inada M; Tsukamoto K; Hirata M; Takita M; Nagasawa K; Miyaura C
Biochem Biophys Res Commun; 2008 Aug; 372(3):434-9. PubMed ID: 18489902
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
Uchiyama S; Yamaguchi M
Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
[TBL] [Abstract][Full Text] [Related]
37. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V
J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568
[TBL] [Abstract][Full Text] [Related]
38. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
39. Anti-Osteoporotic Effects of Combined Extract of
Park E; Kim J; Yeo S; Lim E; Choi CW; Choi S; Li WY; Lee JW; Park JH; Huh D; Jeong SY
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717518
[TBL] [Abstract][Full Text] [Related]
40. Austalides, Osteoclast Differentiation Inhibitors from a Marine-Derived Strain of the Fungus
Wang W; Lee J; Kim KJ; Sung Y; Park KH; Oh E; Park C; Son YJ; Kang H
J Nat Prod; 2019 Nov; 82(11):3083-3088. PubMed ID: 31710223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
